What is the patient acquisition cost for a dermatology clinic in India?

no published specialty benchmark exists; see CPQL benchmarks for national average methodology

Why a blended acquisition cost is close to meaningless

A medical dermatology consult might close at ₹500–₹1,500 in patient value and repeat several times a year. An aesthetic procedure — filler, laser resurfacing, a course of Hydrafacial — can run into five figures per visit and often doesn't repeat for months. Averaging the cost of acquiring both patient types produces a number that describes neither. A clinic that only tracks a single blended acquisition cost can look profitable on paper while its aesthetic funnel quietly bleeds money and its medical funnel subsidises the difference.

The fix is structural, not statistical: track medical and aesthetic acquisition separately, with separate campaigns, separate landing pages and separate cost targets, even inside the same clinic's ad account.

What one clinic's acquisition cost actually looked like

DermaClinix, Gurgaon, is a named ICG client whose cost per qualified lead moved from ₹2,800 to ₹1,080 over 28 weeks without an increase in media budget, with Event Match Quality improving from 4.2 to 8.1 over the same period (see the full case study). That result belongs to one specific engagement, not a sector average — it shows what's achievable when acquisition data is fed back into the platform cleanly, not what a typical dermatology clinic should expect to pay.

What an acceptable cost looks like against ticket size

For aesthetic dermatology specifically, an acquisition cost only makes sense measured against the procedure's ticket value and how often that patient returns. A clinic charging ₹15,000 for a filler session can sustain a materially higher acquisition cost per enquiry than one selling ₹2,000 chemical peels, provided the enquiry-to-consultation-to-treatment conversion rate holds up. That conversion chain — enquiry, consultation booked, consultation attended, procedure booked — is where most of the acquisition budget actually gets lost, usually at the consultation-to-treatment step rather than at the ad-click step.

Absent a specialty benchmark, the national average cost per qualified lead across ICG's healthcare portfolio is ₹2,750, typically falling 38–58% within the first 90 days of a properly instrumented campaign (see CPQL benchmarks). Use that as a planning anchor, then split it by medical versus aesthetic once real campaign data starts coming in.

For the budget side of this question, see what dermatology marketing costs to run — that page covers spend allocation; this one covers what the spend returns.

Detailed answers